Anti-Cancer Drugs Journal Issues Research Articles in November 2023 Edition
November 03, 2023
November 03, 2023
LONDON, England, Nov. 3 -- Anti-Cancer Drugs, a journal that says it reports clinical and experimental results related to anti-cancer drugs and welcomes contributions on anti-cancer drug design, drug delivery, pharmacology, hormonal and biological modalities and chemotherapy evaluation, published research articles on the following topics in its November 2023 edition (Vol. 34, Issue 10):
Review Articles:
* Treatment of neurofibromatosis type II with anlotinib: a case rep . . .
Review Articles:
* Treatment of neurofibromatosis type II with anlotinib: a case rep . . .